Bank of New York Mellon’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8
Closed -$4K 4518
2022
Q3
$4K Hold
8
﹤0.01% 4539
2022
Q2
$6K Sell
8
-53
-87% -$83.2K ﹤0.01% 4569
2022
Q1
$211K Sell
61
-1
-2% -$2.62K ﹤0.01% 4206
2021
Q4
$188K Sell
62
-14
-18% -$65K ﹤0.01% 4291
2021
Q3
$495K Buy
76
+4
+6% +$34.5K ﹤0.01% 3813
2021
Q2
$950K Buy
72
+4
+6% +$62.9K ﹤0.01% 3449
2021
Q1
$1.15M Sell
68
-2
-3% -$39K ﹤0.01% 3250
2020
Q4
$1.19M Sell
70
-4
-5% -$75.3K ﹤0.01% 3168
2020
Q3
$1.38M Sell
74
-17
-19% -$391K ﹤0.01% 2915
2020
Q2
$2.4M Buy
91
+28
+44% +$793K ﹤0.01% 2575
2020
Q1
$1.39M Buy
63
+28
+80% +$447K ﹤0.01% 2751
2019
Q4
$320K Sell
35
-4
-10% -$38.6K ﹤0.01% 3778
2019
Q3
$371K Buy
39
+7
+22% +$85.2K ﹤0.01% 3695
2019
Q2
$506K Buy
32
+9
+39% +$149K ﹤0.01% 3594
2019
Q1
$485K Hold
23
﹤0.01% 3571
2018
Q4
$283K Buy
23
+7
+44% +$121K ﹤0.01% 3736
2018
Q3
$389K Sell
16
-1
-6% -$30.5K ﹤0.01% 3748
2018
Q2
$568K Buy
17
+4
+31% +$153K ﹤0.01% 3575
2018
Q1
$531K Buy
13
+4
+44% +$152K ﹤0.01% 3560
2017
Q4
$409K Hold
9
﹤0.01% 3691
2017
Q3
$540K Buy
+9
New +$494K ﹤0.01% 3555

Other funds holding KALA

Bank of New York Mellon's KALA Position: Q4 2022 in Review

Bank of New York Mellon sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 8 shares — an estimated $4K sold.

Bank of New York Mellon first reported a position in KALA in Q3 2017 and held it in 21 quarters. The position peaked at $2.4M in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • Bank of New York Mellon reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 8 KALA BIO shares in Q4 2022, an estimated $4K.
  • Bank of New York Mellon first reported a position in KALA BIO in Q3 2017 and held it in 21 quarters.
  • Bank of New York Mellon's KALA BIO position peaked at $2.4M in Q2 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.